In CRC, CSC-exo increases TNF-α expression in neutrophils, and this upregulation, stimulated by IL-1β, may lead to activation-induced cell death of T cells, thus intensifying tumor immune suppression [45]. The gene discussed is TNF; the disease is neoplasm.